System-generated · Agent desk · Conviction · stock · inception 2026-07-04
Started with ₹10,00,000 · max 10% per position (10 slots).
An agent-run trading desk over Atlas’s ranks (forward-only).
This rulebook was chosen by the system’s walk-forward search, not hand-written — the exact filters above are what won on out-of-sample data. See the Learning log below for how it got here and what it rejected.
Thick bar = this portfolio · thin bar = NIFTY 500 sector weight.
| Instrument | Sector | Qty | Avg cost | Last | Value | Weight | P&L | Comp | Tech | Flow | Val | RS 3M | EMA 50/200 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZYDUSLIFE Zydus Lifesciences Limited | Pharma | 85 | 1153.00 | 1159.00 | ₹98,515 | 10.0% | +0.5% | 96 | 100 | 60 | 34 | +23.3% | ✓/✓ |
| LAURUSLABS Laurus Labs Limited | Pharma | 65 | 1528.00 | 1507.40 | ₹97,981 | 9.9% | -1.3% | 86 | 90 | 50 | 0 | +34.0% | ✓/✓ |
| NEULANDLAB Neuland Laboratories Limited | Healthcare | 5 | 18988.00 | 19542.00 | ₹97,710 | 9.9% | +2.9% | 97 | 100 | 68 | 8 | +27.4% | ✓/✓ |
| IPCALAB IPCA Laboratories Limited | Pharma | 55 | 1782.40 | 1770.40 | ₹97,372 | 9.9% | -0.7% | 96 | 100 | 58 | 17 | +18.3% | ✓/✓ |
| KARURVYSYA Karur Vysya Bank Limited | Banking | 326 | 304.15 | 295.65 | ₹96,382 | 9.8% | -2.8% | 92 | 95 | 60 | 20 | +1.7% | ✓/✓ |
| MAHABANK Bank of Maharashtra | Banking | 1,096 | 91.04 | 82.01 | ₹89,883 | 9.1% | -9.9% | 83 | 88 | 42 | 48 | +12.9% | ✗/✓ |
Lessons earned from outcomes (confidence-weighted, weekly reflection)
50% Do not reject a candidate solely on weak 3‑month relative strength (<0.05); IPCALAB was omitted for low RS yet rose +2.97% in 5 days, showing missed upside. [basis: IPCALAB rejected (weak 3‑month RS) but posted +2.97% T+5]
50% Apply a hard stop of roughly –5% within the first 5 days; MAHABANK fell –9.92% in 5 days, illustrating the damage from unchecked downside. [basis: MAHABANK buy –9.92% T+5; large early loss]
50% In a constructive regime, let a new long position that is +2% or more in the first 5 days run; NEULANDLAB generated +2.92% in 5 days and continued its up‑trend. [basis: NEULANDLAB buy +2.92% T+5; positive short‑term momentum held]
| Date | Instrument | Side | Qty | Price | Value | Cost | Realized P&L | Days | Bucket | Tax | Reason |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-08 | ZYDUSLIFE | buy | 85 | 1153.00 | ₹98,005 | ₹115.65 | — | — | — | — | manual |
| 2026-07-07 | KARURVYSYA | buy | 326 | 304.15 | ₹99,153 | ₹117.00 | — | — | — | — | manual |
| 2026-07-07 | IPCALAB | buy | 55 | 1782.40 | ₹98,032 | ₹115.68 | — | — | — | — | manual |
| 2026-07-03 | MAHABANK | buy | 1,096 | 91.04 | ₹99,780 | ₹117.74 | — | — | — | — | manual |
| 2026-07-03 | LAURUSLABS | buy | 65 | 1528.00 | ₹99,320 | ₹117.20 | — | — | — | — | manual |
| 2026-07-03 | NEULANDLAB | buy | 5 | 18988.00 | ₹94,940 | ₹112.03 | — | — | — | — | manual |